Abstract:Background: Bladder cancer is the most common malignancy of the urinary system, and the search for new and reliable biomarkers has important clinical significance for the personalized treatment of bladder cancer. This study aims to explore the correlation between nuclear proliferation antigen (Ki-67) or Profilin-1 (PFN1) levels, clinicopathological characteristics, and postoperative prognosis in patients with bladder cancer. Methods: Patients with bladder cancer who underwent transurethral resection of bladder cancer tumor in The Fourth Affiliated Hospital of Soochow University, hospital from January 2019 to January 2021 were selected as the study group (n = 60), and patients with benign lesions of bladder cancer during the same period were selected as the control group (n = 60). The expression of Ki-67 and PFN1 in tumor and bladder tissues of the two groups was analyzed. Ki-67 recorded the patient's pathological parameters and calculated the patient's postoperative prognosis. The correlation between Ki-67 and PFN1 expression levels, pathological parameters, and postoperative prognosis was analyzed. Results: The positive expression rates of Ki-67 and PFN1 in the study group were 63.33% and 73.33%, respectively, which were significantly higher than the positive expression rates in the control group (χ2 = 14.803, 17.757, p < 0.001). The positive expression rates of Ki-67 and PFN1 were related to histological grade, clinical stage, infiltration, and lymph node metastasis, and the differences were statistically significant (p 0.05). The survival time and three-year survival rate of the Ki-67 positive expression group were significantly lower than those of the Ki-67 negative expression group (p < 0.05). The survival time and three-year survival rate of the PFN1 positive expression group were significantly lower than those of the PFN1 negative expression group (p < 0.05). Conclusion: The positive expression rates of Ki-67 and PFN1 in bladder tumor tissue are significantly higher than those in bladder tissue, and pathological pattern, histological grade, clinical stage, infiltration, and lymph node metastasis are related to the positive expression rates of Ki-67 and PFN1, and different genders, ages, tumors diameter and vascular invasion are not related to the positive expression rates of Ki-67 and PFN1. The survival time and three-year survival rates of bladder cancer patients with Ki-67 positive and PFN1 positive expression are shorter.

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Relationship of VEGF,PCNA,Survivin and pathological grading,clinical stage of bladder cancer

Expressions Correlation of P53,vegf,cox-2 and EGFR in Bladder Cancer and Their Clinical Significance

The Relationship Between the Expression of Mutant p53 and VEGF and the Clinical Significances in Transitional Cell Carcinoma of the Bladder

Microarray study on the expression of p53,VEGF,E-cad and CK20 in bladder tumor

The Expressions of Survlvin,p53 and Ki-67 in Bladder Cancer

The Expression of p16 and p53 Tumor Suppressor Gene in Bladder Carcinoma

Relationship between the expression of mutant P53 and PCNA and their clinical significances in transitional cell carcinoma of the bladder

Expressions of P53, Nm23, Bcl-2 in Bladder Transitional Cell Carcinoma and Its Clinical Significance

The Relationship of VEGF C Expression and Prognosis of Bladder Transitional Cell Carcinoma

Expressions and clinical significances of PTEN and P53 gene in non-muscle-invasive bladder cancer

The expression of Smad-4 and VEGF in human bladder urothelial carcinoma and their clinical significances

Ki-67 protein expression as significant prognostic factors in human bladder carcinoma

Research of C-Flip,bcl-2 and Ki-67 Expression in Bladder Urothelial Carcinomas and Their Relation with Clinical Pathology and Prognosis

Expression of CUGBP1 and VEGF in Bladder Cancer and Their Clinical Significance

Correlation between Ki-67 or Profilin-1 Expression Levels, Clinicopathological Characteristics and Postoperative Prognosis in Patients with Bladder Cancer

Relationship of TP53 and Ki67 expression in bladder cancer under WHO 2004 classification.

P27,VEGF in bladder rransitional cell carcinoma and its clinical significance

Expression Correlation of Ki67 to P53,VEGF,and C-erbB-2 Genes in Breast Cancer and Their Clinical Significances

The Significance of the Expression of DLL4 and VEGF in Patients with Bladder Transitional Cell Carcinoma

MMP28 Expression in Blander Cancer and Its Clinical Significance